The impact of pregnancy on urinary ketorolac metabolites after single intravenous bolus

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 38, Issue 1, 2013, Pages 1-4

  Kulo, Aida ^a,b   Hendrickx, Sarah ^a   De Hoon, Jan ^a   Mulabegovic, Nedzad ^b   Van Calsteren, Kristel ^a   Verbesselt, Rene ^a   Allegaert, Karel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Drug metabolism; Ketorolac; Oxidation; Pregnancy

Indexed keywords

4 HYDROXY KETOROLAC; DRUG METABOLITE; GLUCURONIDE; KETOROLAC; KETOROLAC GLUCURONIDE; KETOROLAC TROMETAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG URINE LEVEL; FEMALE; HUMAN; METABOLITE; OUTCOME ASSESSMENT; OXIDATION KINETICS; PREGNANCY OUTCOME; PUERPERIUM; URINALYSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BELGIUM; BIOTRANSFORMATION; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; FEMALE; GLUCURONIDES; HUMANS; HYDROXYLATION; INJECTIONS, INTRAVENOUS; KETOROLAC TROMETHAMINE; METABOLIC CLEARANCE RATE; POSTPARTUM PERIOD; PREGNANCY; TOLMETIN;

EID: 84874659734     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-012-0108-7     Document Type: Article

References (10)

1. Brocks DR, Jamali F (1992) Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 23:415-427
2. Feghali MN, Mattison DR (2011) Clinical therapeutics in pregnancy. J Biomed Biotech 2011:ID 783528
3. Kauffman RE, Lieh-Lai MW, Uy HG, Aravind MK (1999) Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. Clin Pharmacol Ther 65:382-388 (Pubitemid 29196540)
4. Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CA (2012a) Pharmacokinetics of paracetamol and its metabolites in women at delivery and postpartum. Br J Clin Pharmacol. doi: 10.1111/j.1365-2125.2012.04402.x
5. Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, Allegaert K (2012b) The impact of caesarean delivery on paracetamol and ketorolac pharmacokinetics: a paired analysis. J Biomed Biotechnol 2012:437639
6. Kulo A, van de Velde M, van Calsteren K, Smits A, de Hoon J, Verbesselt R, Deprest J, Allegaert K (2012c) Pharmacokinetics of intravenous ketorolac following caesarean delivery. Int J Obstet Anesth. doi: 10.1016/j.ijoa.2012.06. 001
7. Mroszczak EJ, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, Tokes LG, Maddox ML, Cho DK (1987) Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 15:618-626 (Pubitemid 18004616)
8. Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I (1990) Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 10:33S-39S
9. Tsina I, Tam YL, Boyd A, Rocha C, Massey I, Tarnowski T (1996) An indirect (derivatization) and a direct HPLC method for the determination of the enantiomers of ketorolac in plasma. J Pharm Biomed Anal 15:403-417 (Pubitemid 26384361)
10. Wang Z, Dsida RM, Avram MJ (2001) Determination of ketorolac in human plasma by reversed-phase high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. J Chromatogr B Biomed Sci Appl 755:383-386 (Pubitemid 32324109)